Dhx37-flox Mouse
一般名
Dhx37-flox
製品ID
S-CKO-05297
背景情報
C57BL/6JCya
系統ID
CKOCMP-208144-Dhx37-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Dhx37-flox Mouse(カタログ番号S-CKO-05297)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Dhx37-flox
系統ID
CKOCMP-208144-Dhx37-B6J-VA
遺伝子名
製品ID
S-CKO-05297
遺伝子別名
Gm451, Gm1050, mKIAA1517
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 5
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000169485
NCBIトランスクリプトID
NM_203319
ターゲット領域
Exon 2
有効領域の大きさ
~1.5 kb
遺伝子研究の概要
Dhx37, encoding a helicase from the DExD/H-box family, is essential for ribosome biogenesis in eukaryotes [1,2]. It likely participates in fundamental cellular processes related to ribosome-associated functions, which are crucial for normal cell growth and development.
Variants in Dhx37 have been associated with multiple disorders. In 46,XY individuals, missense variants in Dhx37 are linked to gonadal dysgenesis, testicular regression syndrome (TRS), or anorchia, suggesting its role in male sex development pathway, especially in testis determination and maintenance [1,2,6,8,9]. In hepatocellular carcinoma (HCC), higher Dhx37 expression is correlated with poor prognosis, and it may be a potential target for inhibiting tumor progression, as it activates cell cycle, DNA repair, chemokine signaling pathways, and regulates immune response [3,5,7]. Also, in CD8 T cells, Dhx37 knockout enhanced the efficacy of antigen-specific CD8 T cells against triple-negative breast cancer, indicating it suppresses effector functions, cytokine production, and T cell activation [4].
In conclusion, Dhx37 is vital for ribosome biogenesis. Its variants are associated with disorders of sex development in 46,XY individuals and play roles in cancer progression and immune cell regulation. The study of Dhx37 through gene knockout models in these contexts has enhanced our understanding of its functions and its implications in disease.
References:
1. McElreavey, Kenneth, Pailhoux, Eric, Bashamboo, Anu. 2022. DHX37 and 46,XY DSD: A New Ribosomopathy? In Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation, 16, 194-206. doi:10.1159/000522004. https://pubmed.ncbi.nlm.nih.gov/35835064/
2. de Oliveira, Felipe Rodrigues, Guaragna, Mara Sanches, Maciel-Guerra, Andréa Trevas, Guerra-Junior, Gil, Fabbri-Scallet, Helena. 2023. DHX37 and the Implications in Disorders of Sex Development: An Update Review. In Hormone research in paediatrics, 97, 433-444. doi:10.1159/000535969. https://pubmed.ncbi.nlm.nih.gov/38142677/
3. Liu, Nanbin, Zhang, Hailong, Zhang, Chunli, Li, Zongfang, Tian, Hongwei. 2023. DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. In Cancers, 15, . doi:10.3390/cancers15215228. https://pubmed.ncbi.nlm.nih.gov/37958405/
4. Dong, Matthew B, Wang, Guangchuan, Chow, Ryan D, Herbst, Roy S, Chen, Sidi. . Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. In Cell, 178, 1189-1204.e23. doi:10.1016/j.cell.2019.07.044. https://pubmed.ncbi.nlm.nih.gov/31442407/
5. Liu, Zhen, Ye, Youqiong, Liu, Yizhe, Chen, Zhiao, He, Xianghuo. . RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1. In Cancer research, 82, 1937-1952. doi:10.1158/0008-5472.CAN-21-3038. https://pubmed.ncbi.nlm.nih.gov/35290436/
6. de Oliveira, Felipe Rodrigues, Mazzola, Taís Nitsch, de Mello, Maricilda Palandi, Guerra-Junior, Gil, Fabbri-Scallet, Helena. 2023. DHX37 and NR5A1 Variants Identified in Patients with 46,XY Partial Gonadal Dysgenesis. In Life (Basel, Switzerland), 13, . doi:10.3390/life13051093. https://pubmed.ncbi.nlm.nih.gov/37240737/
7. Xu, Yanni, Jiang, Qiongchao, Liu, Hejun, Saw, Phei Er, Luo, Baoming. 2020. DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration. In Journal of immunology research, 2020, 8835393. doi:10.1155/2020/8835393. https://pubmed.ncbi.nlm.nih.gov/33490290/
8. Peng, Huifang, Peng, Wenyuan, Chen, Jiali, Ma, Yujin, Jiang, Hongwei. 2025. Profile of DHX37 gene defects in human genetic diseases: 46,XY disorders of sex development. In Frontiers in endocrinology, 16, 1507749. doi:10.3389/fendo.2025.1507749. https://pubmed.ncbi.nlm.nih.gov/40026690/
9. Shimura, Kazuhiro, Ichihashi, Yosuke, Nakano, Satsuki, Hasegawa, Tomonobu, Ishii, Tomohiro. 2024. DHX37 Variant Is One of the Common Genetic Causes in Japanese Patients with Testicular Regression Syndrome/Partial Gonadal Dysgenesis without Müllerian Derivatives. In Hormone research in paediatrics, 98, 206-213. doi:10.1159/000537761. https://pubmed.ncbi.nlm.nih.gov/38359811/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
